↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Nobili F.) "

Search: WFRF:(Nobili F.)

Result 61-70 of 88

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
61.	Fischler, B, et al. (author) Similarities and Differences in Allocation Policies for Pediatric Liver Transplantation Across the World 2019 In: Journal of pediatric gastroenterology and nutrition. - 1536-4801. ; 68:5, s. 700-705 Journal article (peer-reviewed)
62.	Franciotti, R, et al. (author) Anterior EEG slowing in dementia with Lewy bodies: a multicenter European cohort study 2020 In: Neurobiology of aging. - : Elsevier BV. - 1558-1497 .- 0197-4580. ; 93, s. 55-60 Journal article (peer-reviewed)
63.	Frederiksen, KS, et al. (author) Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey 2021 In: International journal of geriatric psychiatry. - : Wiley. - 1099-1166 .- 0885-6230. ; 36:2, s. 324-333 Journal article (peer-reviewed)
64.	Frisoni, Giovanni B., et al. (author) European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders 2024 In: The Lancet Neurology. - 1474-4422 .- 1474-4465. ; 23:3, s. 302-312 Research review (peer-reviewed)abstract The recent commercialisation of the first disease-modifying drugs for Alzheimer's disease emphasises the need for consensus recommendations on the rational use of biomarkers to diagnose people with suspected neurocognitive disorders in memory clinics. Most available recommendations and guidelines are either disease-centred or biomarker-centred. A European multidisciplinary taskforce consisting of 22 experts from 11 European scientific societies set out to define the first patient-centred diagnostic workflow that aims to prioritise testing for available biomarkers in individuals attending memory clinics. After an extensive literature review, we used a Delphi consensus procedure to identify 11 clinical syndromes, based on clinical history and examination, neuropsychology, blood tests, structural imaging, and, in some cases, EEG. We recommend first-line and, if needed, second-line testing for biomarkers according to the patient's clinical profile and the results of previous biomarker findings. This diagnostic workflow will promote consistency in the diagnosis of neurocognitive disorders across European countries.
65.	Garavini, G, et al. (author) ESC Observations of SN 2005cf: II. Optical Spectroscopy and the High Velocity Features 2007 In: The Astrophysical Journal. ; 471, s. 527- Journal article (peer-reviewed)
66.	Garibotto, V, et al. (author) Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 2017 In: Neurobiology of aging. - : Elsevier BV. - 1558-1497 .- 0197-4580. ; 52, s. 183-195 Journal article (peer-reviewed)
67.	Indolfi, G, et al. (author) Treatment and monitoring of children with chronic hepatitis C in the Pre-DAA era: A European survey of 38 paediatric specialists 2019 In: Journal of viral hepatitis. - : Wiley. - 1365-2893 .- 1352-0504. ; 26:8, s. 961-968 Journal article (peer-reviewed)
68.	Kapucu, OL, et al. (author) EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2 2009 In: European journal of nuclear medicine and molecular imaging. - : Springer Science and Business Media LLC. - 1619-7089 .- 1619-7070. ; 36:12, s. 2093-2102 Journal article (peer-reviewed)
69.	Koch, W, et al. (author) Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls 2014 In: European journal of nuclear medicine and molecular imaging. - : Springer Science and Business Media LLC. - 1619-7089 .- 1619-7070. ; 41:10, s. 1938-1946 Journal article (peer-reviewed)
70.	Kruse, N., et al. (author) Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 2015 In: Neurobiology of Aging. - : Elsevier BV. - 0197-4580. ; 36:9, s. 2587-2596 Journal article (peer-reviewed)abstract Decreased levels of alpha-synuclein (aSyn) in cerebrospinal fluid (CSF) in Parkinson's disease and related synucleinopathies have been reported, however, not consistently in all cross-sectional studies. To test the performance of one recently released human-specific enzyme-linked immunosorbent assay (ELISA) for the quantification of aSyn in CSF, we carried out a round robin trial with 18 participating laboratories trained in CSF ELISA analyses within the BIOMARKAPD project in the EU Joint Program -Neurodegenerative Disease Research. CSF samples (homogeneous aliquots from pools) and ELISA kits (one lot) were provided centrally and data reported back to one laboratory for data analysis. Our study showed that although factors such as preanalytical sample handling and lot-to-lot variability were minimized by our study design, we identified high variation in absolute values of CSF aSyn even when the same samples and same lots of assays were applied. We further demonstrate that although absolute concentrations differ between laboratories the quantitative results are comparable. With further standardization this assay may become an attractive tool for comparing aSyn measurements in diverse settings. Recommendations for further validation experiments and improvement of the interlaboratory results obtained are given. (C) 2015 Elsevier Inc. All rights reserved.

Skapa referenser, mejla, bekava och länka

Permalink

Result 61-70 of 88

Refine your search

Type of publication: journal article (78); conference paper (7); research review (3)

Type of content: peer-reviewed (81); other academic/artistic (7)

Author/Editor: Nobili, F (67); Frisoni, GB (21); Varrone, A (19); Tsolaki, M (18); Soricelli, A (16); Babiloni, C (15); show more...; Aarsland, D (14); Bonanni, L (14); Visser, PJ (14); Booij, J (14); Van Laere, K (14); Tatsch, K (14); Parnetti, L (13); Pagani, M (12); Hampel, H. (12); Taylor, JP (11); Lizio, R (11); Scheltens, P (11); Marizzoni, M (10); Tossici-Bolt, L (10); Asenbaum, S (10); Darcourt, J (10); Sabri, O (10); Noce, G (10); Ferri, R (10); Arnaldi, D (10); Franciotti, R (10); Onofrj, M (10); Didic, M (9); Sera, T (9); Lopez, S (9); Fama, F (9); Rossini, PM (8); Nobili, V (8); Hanoglu, L (8); Buttinelli, C (8); Giubilei, F (8); Fuhr, P (8); Gschwandtner, U (8); Ransmayr, G (8); Salvatore, M (7); Fischler, B (7); Soininen, H (7); Ferrari, C. (7); Dubois, B (7); Wiltfang, J (7); Dickson, JC (7); Vander Borght, T (7); Frisoni, G. B. (7); Orzi, F (7); show less...

University: Karolinska Institutet (71); Lund University (10); University of Gothenburg (9); Stockholm University (7); Chalmers University of Technology (3); Linköping University (2); show more...; Umeå University (1); Uppsala University (1); Örebro University (1); Linnaeus University (1); Swedish University of Agricultural Sciences (1); show less...

Language: English (88)

Research subject (UKÄ/SCB): Medical and Health Sciences (15); Natural sciences (5); Engineering and Technology (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view